However, by considering patients' individual circumstances and taking the time to ensure that they use the appropriate inhaler and technique, everyone can benefit. Asthma and COPD have a huge ...

The current model for managing chronic obstructive pulmonary disease (COPD) generally considers inhalers from the same therapeutic class to be clinically equivalent.1 When a long-acting muscarinic ...

Does gabapentinoid use increase the risk of severe exacerbation in patients with chronic obstructive pulmonary disease (COPD) ...

Medicare usually covers the cost of inhalers for people with asthma, COPD, or certain other conditions ... provide advice regarding the purchase or use of any insurance or insurance products.

ICER assessed GSK's COPD inhalers, Trelegy Ellipta and Breo Ellipta, for Medicare price negotiations, highlighting their once-daily dosing and comparable net health benefits.

So a COPD exacerbation is a period where people ... And finally a lot of the inhalers and the medications that we use, a lot of them have been studied extensively and have been shown to reduce ...

Patients with COPD had better inhaler adherence when invited to enroll in a program that lowers cost sharing for maintenance inhalers and offers medication management services, according to results ...

The Hailie Smartinhaler device has also been cleared for use with inhalers from other manufacturers ... directly to patients with asthma and COPD under a 510(k) over-the-counter clearance.

A new study published in the CHEST journal found that ensifentrine, an innovative inhaled therapy, significantly reduces the ...

The Institute for Clinical and Economic Review has prepared a special report on Trelegy and Breo, two therapies that treat ...

For patients with type 2 diabetes (T2D) and chronic obstructive pulmonary disorder (COPD), sodium-glucose cotransporter-2 ...